Cargando…

Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo′' to inhibition by the carbon monoxide-releasing molecule, CORM-3()(): N-acetylcysteine reduces CO-RM uptake and inhibition of respiration

Background: CO-releasing molecules (CO-RMs) are potential therapeutic agents, able to deliver CO – a critical gasotransmitter – in biological environments. CO-RMs are also effective antimicrobial agents; although the mechanisms of action are poorly defined, haem-containing terminal oxidases are prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Jesse, Helen E., Nye, Tacita L., McLean, Samantha, Green, Jeffrey, Mann, Brian E., Poole, Robert K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Pub. Co 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787766/
https://www.ncbi.nlm.nih.gov/pubmed/23624261
http://dx.doi.org/10.1016/j.bbapap.2013.04.019
_version_ 1782286230154641408
author Jesse, Helen E.
Nye, Tacita L.
McLean, Samantha
Green, Jeffrey
Mann, Brian E.
Poole, Robert K.
author_facet Jesse, Helen E.
Nye, Tacita L.
McLean, Samantha
Green, Jeffrey
Mann, Brian E.
Poole, Robert K.
author_sort Jesse, Helen E.
collection PubMed
description Background: CO-releasing molecules (CO-RMs) are potential therapeutic agents, able to deliver CO – a critical gasotransmitter – in biological environments. CO-RMs are also effective antimicrobial agents; although the mechanisms of action are poorly defined, haem-containing terminal oxidases are primary targets. Nevertheless, it is clear from several studies that the effects of CO-RMs on biological systems are frequently not adequately explained by the release of CO: CO-RMs are generally more potent inhibitors than is CO gas and other effects of the molecules are evident. Methods: Because sensitivity to CO-RMs cannot be predicted by sensitivity to CO gas, we assess the differential susceptibilities of strains, each expressing only one of the three terminal oxidases of E. coli — cytochrome bd-I, cytochrome bd-II and cytochrome bo′, to inhibition by CORM-3. We present the first sensitive measurement of the oxygen affinity of cytochrome bd-II (K(m) 0.24 μM) employing globin deoxygenation. Finally, we investigate the way(s) in which thiol compounds abolish the inhibitory effects of CORM-2 and CORM-3 on respiration, growth and viability, a phenomenon that is well documented, but poorly understood. Results: We show that a strain expressing cytochrome bd-I as the sole oxidase is least susceptible to inhibition by CORM-3 in its growth and respiration of both intact cells and membranes. Growth studies show that cytochrome bd-II has similar CORM-3 sensitivity to cytochrome bo′. Cytochromes bo′ and bd-II also have considerably lower affinities for oxygen than bd-I. We show that the ability of N-acetylcysteine to abrogate the toxic effects of CO-RMs is not attributable to its antioxidant effects, or prevention of CO targeting to the oxidases, but may be largely due to the inhibition of CO-RM uptake by bacterial cells. Conclusions: A strain expressing cytochrome bd-I as the sole terminal oxidase is least susceptible to inhibition by CORM-3. N-acetylcysteine is a potent inhibitor of CO-RM uptake by E. coli. General significance: Rational design and exploitation of CO-RMs require a fundamental understanding of their activity. CO and CO-RMs have multifaceted effects on mammalian and microbial cells; here we show that the quinol oxidases of E. coli are differentially sensitive to CORM-3. This article is part of a Special Issue entitled: Oxygen Binding and Sensing Proteins.
format Online
Article
Text
id pubmed-3787766
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier Pub. Co
record_format MEDLINE/PubMed
spelling pubmed-37877662013-10-03 Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo′' to inhibition by the carbon monoxide-releasing molecule, CORM-3()(): N-acetylcysteine reduces CO-RM uptake and inhibition of respiration Jesse, Helen E. Nye, Tacita L. McLean, Samantha Green, Jeffrey Mann, Brian E. Poole, Robert K. Biochim Biophys Acta Article Background: CO-releasing molecules (CO-RMs) are potential therapeutic agents, able to deliver CO – a critical gasotransmitter – in biological environments. CO-RMs are also effective antimicrobial agents; although the mechanisms of action are poorly defined, haem-containing terminal oxidases are primary targets. Nevertheless, it is clear from several studies that the effects of CO-RMs on biological systems are frequently not adequately explained by the release of CO: CO-RMs are generally more potent inhibitors than is CO gas and other effects of the molecules are evident. Methods: Because sensitivity to CO-RMs cannot be predicted by sensitivity to CO gas, we assess the differential susceptibilities of strains, each expressing only one of the three terminal oxidases of E. coli — cytochrome bd-I, cytochrome bd-II and cytochrome bo′, to inhibition by CORM-3. We present the first sensitive measurement of the oxygen affinity of cytochrome bd-II (K(m) 0.24 μM) employing globin deoxygenation. Finally, we investigate the way(s) in which thiol compounds abolish the inhibitory effects of CORM-2 and CORM-3 on respiration, growth and viability, a phenomenon that is well documented, but poorly understood. Results: We show that a strain expressing cytochrome bd-I as the sole oxidase is least susceptible to inhibition by CORM-3 in its growth and respiration of both intact cells and membranes. Growth studies show that cytochrome bd-II has similar CORM-3 sensitivity to cytochrome bo′. Cytochromes bo′ and bd-II also have considerably lower affinities for oxygen than bd-I. We show that the ability of N-acetylcysteine to abrogate the toxic effects of CO-RMs is not attributable to its antioxidant effects, or prevention of CO targeting to the oxidases, but may be largely due to the inhibition of CO-RM uptake by bacterial cells. Conclusions: A strain expressing cytochrome bd-I as the sole terminal oxidase is least susceptible to inhibition by CORM-3. N-acetylcysteine is a potent inhibitor of CO-RM uptake by E. coli. General significance: Rational design and exploitation of CO-RMs require a fundamental understanding of their activity. CO and CO-RMs have multifaceted effects on mammalian and microbial cells; here we show that the quinol oxidases of E. coli are differentially sensitive to CORM-3. This article is part of a Special Issue entitled: Oxygen Binding and Sensing Proteins. Elsevier Pub. Co 2013-09 /pmc/articles/PMC3787766/ /pubmed/23624261 http://dx.doi.org/10.1016/j.bbapap.2013.04.019 Text en © 2013 The Authors https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license
spellingShingle Article
Jesse, Helen E.
Nye, Tacita L.
McLean, Samantha
Green, Jeffrey
Mann, Brian E.
Poole, Robert K.
Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo′' to inhibition by the carbon monoxide-releasing molecule, CORM-3()(): N-acetylcysteine reduces CO-RM uptake and inhibition of respiration
title Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo′' to inhibition by the carbon monoxide-releasing molecule, CORM-3()(): N-acetylcysteine reduces CO-RM uptake and inhibition of respiration
title_full Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo′' to inhibition by the carbon monoxide-releasing molecule, CORM-3()(): N-acetylcysteine reduces CO-RM uptake and inhibition of respiration
title_fullStr Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo′' to inhibition by the carbon monoxide-releasing molecule, CORM-3()(): N-acetylcysteine reduces CO-RM uptake and inhibition of respiration
title_full_unstemmed Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo′' to inhibition by the carbon monoxide-releasing molecule, CORM-3()(): N-acetylcysteine reduces CO-RM uptake and inhibition of respiration
title_short Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo′' to inhibition by the carbon monoxide-releasing molecule, CORM-3()(): N-acetylcysteine reduces CO-RM uptake and inhibition of respiration
title_sort cytochrome bd-i in escherichia coli is less sensitive than cytochromes bd-ii or bo′' to inhibition by the carbon monoxide-releasing molecule, corm-3()(): n-acetylcysteine reduces co-rm uptake and inhibition of respiration
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787766/
https://www.ncbi.nlm.nih.gov/pubmed/23624261
http://dx.doi.org/10.1016/j.bbapap.2013.04.019
work_keys_str_mv AT jessehelene cytochromebdiinescherichiacoliislesssensitivethancytochromesbdiiorbotoinhibitionbythecarbonmonoxidereleasingmoleculecorm3nacetylcysteinereducescormuptakeandinhibitionofrespiration
AT nyetacital cytochromebdiinescherichiacoliislesssensitivethancytochromesbdiiorbotoinhibitionbythecarbonmonoxidereleasingmoleculecorm3nacetylcysteinereducescormuptakeandinhibitionofrespiration
AT mcleansamantha cytochromebdiinescherichiacoliislesssensitivethancytochromesbdiiorbotoinhibitionbythecarbonmonoxidereleasingmoleculecorm3nacetylcysteinereducescormuptakeandinhibitionofrespiration
AT greenjeffrey cytochromebdiinescherichiacoliislesssensitivethancytochromesbdiiorbotoinhibitionbythecarbonmonoxidereleasingmoleculecorm3nacetylcysteinereducescormuptakeandinhibitionofrespiration
AT mannbriane cytochromebdiinescherichiacoliislesssensitivethancytochromesbdiiorbotoinhibitionbythecarbonmonoxidereleasingmoleculecorm3nacetylcysteinereducescormuptakeandinhibitionofrespiration
AT poolerobertk cytochromebdiinescherichiacoliislesssensitivethancytochromesbdiiorbotoinhibitionbythecarbonmonoxidereleasingmoleculecorm3nacetylcysteinereducescormuptakeandinhibitionofrespiration